Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Guido Marcucci Michael R Grever William G Blum James A Zwiebel Rebecca B Klisovic John C. Byrd Zhiliang Xie Cheryl Kefauver Steven M Devine Lenguyen Huynh |
| Publication date | November 1, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |